Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract

NCT01116622 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

Interventions

DRUG: Bexarotene (Targretin®)
DRUG: Erlotinib (Tarceva™)

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]
[object Object]